Malignant neoplasm of prostate
Information
- Disease name
- Malignant neoplasm of prostate
- Disease ID
- Description
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| TP53 | 17 | 7,668,421 | 7,687,490 | 2 |
| BRCA1 | 17 | 43,044,295 | 43,125,483 | 2 |
| RECQL4 | 8 | 144,511,288 | 144,517,833 | 2 |
| AKT1 | 14 | 104,769,349 | 104,794,124 | 2 |
| APC | 5 | 112,737,885 | 112,846,239 | 2 |
| SDHAF2 | 11 | 61,430,124 | 61,446,733 | 2 |
| BRIP1 | 17 | 61,679,139 | 61,863,528 | 2 |
| FANCG | 9 | 35,073,839 | 35,079,942 | 2 |
| EXT2 | 11 | 44,095,717 | 44,244,931 | 2 |
| GOLGA5 | 14 | 92,794,305 | 92,839,947 | 2 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01764646 | Active, not recruiting | N/A | Hypofractionated Radiation Therapy in Prostate Cancer | September 2012 | September 2025 |
| NCT04534075 | Recruiting | Phase 3 | Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial | September 2, 2020 | December 31, 2024 |
| NCT06150417 | Recruiting | Phase 2 | MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) | May 24, 2024 | July 1, 2026 |
| NCT06437496 | Recruiting | Early Phase 1 | 68Ga-AAZTA-093 PET/CT: First-in-human Study | April 1, 2024 | October 1, 2024 |
| NCT04696263 | Suspended | N/A | Single-Port Versus Multi-Port Robotic Radical Prostatectomy | September 1, 2022 | December 1, 2025 |
| NCT04765423 | Withdrawn | N/A | Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease | March 25, 2021 | March 18, 2022 |
- ICD10 preferred id (Insert disease from ICD10)
- D0002107
- ICD10 class code (Insert disease from ICD10)
- C61